Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
US8778916B2 · kind B2 · utility
12Cited by
28References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2012 |
| Grant date | Jul 15, 2014 |
| Priority date | — |
| Expiry date | Aug 14, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.